skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Team, been holding Abbv in my rrsp for a while now, and was down till this morning, now , taking a big loss. After this mornings news, should I buy more, ( I know you are not fans of doubling down) Can they still afford to pay their dividend? I thank you in advance! Sam

Read Answer Asked by sam on June 26, 2019
Q: AGN has received a $188.24/s stock+cash offer from ABBV, yet (pre-market) its shares aren't breaking above $173. In this sort of situation, isn't it more typical for the share price to overshoot the offer (given the chance of another bid)? Or is the market doubtful that any deal will be completed?
Read Answer Asked by John on June 25, 2019
Q: Hi 5i,
I have some USD set aside to purchase Pfizer (PFE:US) and have a window of up until about Aug.5th give or take, having missed the latest dividend. So, I am in no real hurry. My question is: should I just proceed and purchase now or wait to see if there is any kind of pull-back presenting a better entry point between now and August? I see it has continued to grind higher over the past while.
Your thoughts would be appreciated.
Thanks!!
Cheers,
Mike
Read Answer Asked by Mike on June 25, 2019
Q: As the opportunity arises, I need to lessen my overweight position in SIS. Would SYK be an attractive substitute in a sector that, like SIS, is right for the times as the general population ages and are increasingly in deteriorating physical shape. Is there any other company with these dynamics that I should look at?
Read Answer Asked by Geoffrey on June 24, 2019
Q: Last question on this company dates back to 2017. It has had a nice ride up; but is currently taking an ugly and fast ride down. Down 15% for me in about 1 week alone. My “rules” say sell! Should I? Or can hanging in anticipation of a turnaround be justified?

What does the future look like for this company based on your analysis?

Thanks.
Read Answer Asked by Donald on June 13, 2019
Q: While the market remains buoyant, Knight's CEO seems to be remaining patient for a major reset bringing potential buyout company prices spiralling downward. I am ok with that but he seems to have laid an egg with TherapeuticsMD by paying $20M for rights to just two of their drugs for Canada and Israel plus buying $20M of stock at $5.10 and is now down over 40% in a short time frame. What do you think of this deal and the potential of these drugs? It was, at least, good to see one company pay for rights to the rest of the world outside the US. Are they a legitimate partner?
Thanks.
Read Answer Asked by Steven on June 11, 2019
Q: I don’t like to add to my losers but the price drop of SIS makes it tempting. The stock is still an expensive one but do you think the dividend will start to give it some support? I’m concidering bringing this back up to a 2.5% position as I feel there’s lots of growth potential and I have a long time horizon.
Read Answer Asked by Dennis on June 11, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!